COVID-19 Vaccines
Dosage interval of Covishield vaccine revised to 4 to 8 weeks
1 min read
By Ministry of Health and Family Welfare - 23 March 2021, Updated on - 18 October 2022
Share this article
3
13 likes
COVID-19 Vaccines
Leave Comment
Recommended for you
COVID-19 Vaccines
Top things you should know about Corbevax: The COVID-19 Vaccine for kids
Corbevax is a safe and effective COVID-19 vaccine that can be administered to kids in the age group of 12 to 14 years to protect them against the contagious coronavirus.
COVID-19 Vaccines
Who Should and Should Not Take the COVID-19 Vaccine?
Although the percentage of adverse events following immunization is very small, it is important to spread awareness about who should get the COVID-19 vaccine and who should not.
COVID-19 Vaccines
How Will Adverse Events after COVID-19 Immunization Be Handled?
To address the problems posed by Adverse Event Following Immunization (AEFI), India’s Ministry of Health and Family Welfare recently released the Operational Guidelines for COVID-19 vaccines.
Subscribe
Sign up for our free Health Library Daily Newsletter
Get doctor-approved health tips, news, and more.
Visual Stories
COVID-19 Vaccine Roundup [22.03.2021]
Tap to continue exploring
Recommended for you
COVID-19 Vaccines
Top things you should know about Corbevax: The COVID-19 Vaccine for kids
Corbevax is a safe and effective COVID-19 vaccine that can be administered to kids in the age group of 12 to 14 years to protect them against the contagious coronavirus.
COVID-19 Vaccines
Who Should and Should Not Take the COVID-19 Vaccine?
Although the percentage of adverse events following immunization is very small, it is important to spread awareness about who should get the COVID-19 vaccine and who should not.
COVID-19 Vaccines
How Will Adverse Events after COVID-19 Immunization Be Handled?
To address the problems posed by Adverse Event Following Immunization (AEFI), India’s Ministry of Health and Family Welfare recently released the Operational Guidelines for COVID-19 vaccines.